Jonas Wuopio, Marju Orho-Melander, Gunnar Engström, Johan Ärnlöv. 'No research without perfect methods': a problematic approach in epidemiology.European heart journal open. 2023, 3 (6): oead093
Lukas Tomas, Pernilla Katra, Wiaam Badn, Linda Andersson, Jan Nilsson, Alexandru Schiopu, Daniel Engelbertsen, Isabel Gonçalves, Eva Bengtsson, Harry Björkbacka. Invariant natural killer T cells and incidence of first-time coronary events: a nested case-control study.European heart journal open. 2023, 3 (6): oead094
Hannah M la Roi-Teeuw, Maarten van Smeden, Geert-Jan Geersing, Olaf H Klungel, Frans H Rutten, Patrick C Souverein, Sander van Doorn. Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and validation study.European heart journal open. 2023, 3 (6): oead101
Kazutoshi Hirose, Koki Nakanishi, Marco R Di Tullio, Shunichi Homma, Naoko Sawada, Yuriko Yoshida, Megumi Hirokawa, Katsuhiro Koyama, Koichi Kimura, Tomoko Nakao, Masao Daimon, Hiroyuki Morita, Makoto Kurano, Issei Komuro. Association between non-alcoholic fatty liver disease and subclinical left ventricular dysfunction in the general population.European heart journal open. 2023, 3 (6): oead108
Norman R C Campbell. The associations between dietary sodium and atherosclerosis: are the methods used accurate and reproducible?European heart journal open. 2023, 3 (6): oead110
David Ferreira, Jack Hardy, Will Meere, Lloyd Butel-Simoes, Michael McGee, Nicholas Whitehead, Paul Healey, Tom Ford, Christopher Oldmeadow, John Attia, Bradley Wilsmore, Nicholas Collins, Andrew Boyle. Safety and care of no fasting prior to catheterization laboratory procedures: a non-inferiority randomized control trial protocol (SCOFF trial).European heart journal open. 2023, 3 (6): oead111
Henrik Almroth, Lars O Karlsson, Carl-Johan Carlhäll, Emmanouil Charitakis. Haemodynamic changes after atrial fibrillation initiation in patients eligible for catheter ablation: a randomized controlled study.European heart journal open. 2023, 3 (6): oead112
Michael Miller, Deepak L Bhatt, Eliot A Brinton, Terry A Jacobson, Philippe Gabriel Steg, Armando Lira Pineda, Steven B Ketchum, Ralph T Doyle, Jean-Claude Tardif, Christie M Ballantyne. Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn.European heart journal open. 2023, 3 (6): oead114
Bart J J Velders, Michiel D Vriesendorp, Rolf H H Groenwold. Preventing immortal time bias in observational studies: a matter of design.European heart journal open. 2023, 3 (6): oead117